Protara Therapeutics, Inc.

NASDAQ:TARA

Biotechnology

Healthcare
$2.34 -1.27%

-$0.05 today

Market cap
$144.07M
Beta
1.45
P/E (TTM)
-2.7
EPS (TTM)
-$1.48
52W Low $2.77High $7.82

Volume 1.15M

Average 0.73M

Balance Sheet

Inspect the capital base behind the business.

Assets

$209.47M

FY 2025 · Annual

+15.4% YoY

Liabilities

$13.06M

FY 2025 · Annual

-8.8% YoY

Equity

$196.41M

FY 2025 · Annual

+17.5% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents35.72M24.13M39.59M162.8M49.66M
Short-term Investments55.51M60.24M25.99M7.49M105.9M
Net Receivables634K486K242K01.26M
Inventory01.16M000
Other Current Assets34K(1.04M)37K2K65K
Total Current Assets93.11M86.15M68.71M172.16M159.5M
Property, Plant & Equipment (Net)8.89M7.87M6.56M5.28M3.93M
Goodwill29.52M0000
Intangible Assets084K2.66M3.25M2.93M
Long-term Investments39.47M17.89M0042.34M
Tax Assets00000
Other Non-current Assets1.61M1.31M1.03M772K765K
Total Non-current Assets79.48M27.14M10.25M9.3M49.96M
Total Assets172.6M113.29M78.95M181.45M209.47M
Account Payables954K1.59M2.43M4.43M3.47M
Short-term Debt00000
Tax Payables41K0000
Deferred Revenue00000
Other Current Liabilities1.8M2.54M2.11M2.53M3.27M
Total Current Liabilities4.3M5.74M6.15M10.96M10.94M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities6.38M5.47M4.48M3.36M2.12M
Total Liabilities10.68M11.21M10.63M14.32M13.06M
Common Stock11K11K11K35K54K
Retained Earnings(94.01M)(159.96M)(200.38M)(244.98M)(302.42M)
Accumulated OCI(211K)(688K)(31K)2K90K
Other Stockholders Equity00000
Minority Interest00000
Total Equity161.91M102.08M68.32M167.13M196.41M
Total Debt7.24M6.38M5.47M4.48M3.36M
Net Debt(28.49M)(17.74M)(34.12M)(158.32M)(46.3M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$14.7M
Short-term Investments$121.0M
Receivables$1.5M
Other Current$2.7M
Total Current Assets$140.0M
PP&E (Net)$3.6M
Intangible Assets$5.9M
Long-term Investments$41.6M
Other Non-current$821.0K
Total Non-current Assets$51.9M
Total Assets$191.9M

Analysis

Selected assets total $191.9M for Latest. The largest visible component is Short-term Investments at $121.0M, about 63.1% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 6, 2026
10-QQuarterly reportNov 6, 2026
SC 13G/ASC 13G/A filingAug 13, 2026
8-KCurrent reportAug 11, 2026
S-8S-8 filingAug 11, 2026

How much cash does TARA have?

Protara Therapeutics, Inc. (TARA) reported $49.66M in cash and equivalents in fiscal 2025.

How much debt does TARA carry?

Protara Therapeutics, Inc. (TARA) reported $3.36M of total debt, with net debt of -$46.30M.